UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sickle cell disease complications: Prevalence and resource utilization

PloS one, 2019-07, Vol.14 (7), p.e0214355-e0214355

2019

Volltextzugriff (PDF)

Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study

Health and quality of life outcomes, 2019-10, Vol.17 (1), p.155-155, Article 155

2019

Volltextzugriff (PDF)

The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease

Quality of life research, 2020-06, Vol.29 (6), p.1533-1547

2020

Volltextzugriff (PDF)

Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease

Health and quality of life outcomes, 2018-05, Vol.16 (1), p.99-99, Article 99

2018

Volltextzugriff (PDF)

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett's Esophagus, and Barrett's Esophagus-Related Neoplasia in the United States

Journal of health economics and outcomes research (Online), 2023, Vol.10 (1), p.51-58

2023

Volltextzugriff (PDF)

1145. Meningococcal B Immunization for Adolescents in the Presence of Added Gonorrhea Protection: A Public Health Impact Modelling Study in the United States

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

A Systematic Literature Review of the Burden of Ischemic Priapism in Patients with Sickle Cell Disease

Blood, 2019-11, Vol.134 (Supplement_1), p.3467-3467

2019

Volltextzugriff (PDF)

For which diseases do broader value elements matter most? An evaluation across 20 ICER evidence reports

Journal of managed care & specialty pharmacy, 2021-05, Vol.27 (5), p.650-659

2021

Volltextzugriff (PDF)

Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer

Clinical breast cancer, 2018-10, Vol.18 (5), p.380-386

2018

Volltextzugriff (PDF)

Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings

Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), 2009-07, Vol.8 (4), p.253-268

2009

Volltextzugriff (PDF)

Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States

Medicine (Baltimore), 2023-03, Vol.102 (12), p.e33072-e33072

2023

Volltextzugriff (PDF)

Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study

Journal of health economics and outcomes research (Online), 2020, Vol.7 (1), p.52-60

2020

Volltextzugriff (PDF)

Cost-Consequence Model Comparing Eltrombopag and Romiplostim for Pediatric Patients with Previously-Treated Chronic Immune Thrombocytopenia

Blood, 2017-12, Vol.130, p.2146-2146

2017

Volltextzugriff (PDF)

A Systematic Literature Review of Patient-Reported Outcome Instruments Used in Sickle Cell Disease

Blood, 2017-12, Vol.130, p.4648-4648

2017

Volltextzugriff (PDF)

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices

Journal of the National Comprehensive Cancer Network, 2015-11, Vol.13 (11), p.1383-1393

2015

Volltextzugriff (PDF)

Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective

Blood, 2019-11, Vol.134 (Supplement_1), p.3464-3464

2019

Volltextzugriff (PDF)

Relationship between Vaso-Occlusive Crisis and Quality of Life: An Analysis of Patients with Sickle Cell Disease in the United States

Blood, 2019-11, Vol.134 (Supplement_1), p.4700-4700

2019

Volltextzugriff (PDF)

How Does Sickle Cell Disease Severity Affect Patient Collection of Disability Insurance and Income: An Analysis of US Survey Data

Blood, 2019-11, Vol.134 (Supplement_1), p.5781-5781

2019

Volltextzugriff (PDF)

Comparison of treatment characteristics between patients diagnosed with immune thrombocytopenia (ITP) and treated with thrombopoietin receptor agonists (TPO-RA)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18314-e18314

2017

Volltextzugriff (PDF)

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

Cost effectiveness and resource allocation, 2011-05, Vol.9 (1), p.5-5

2011

Volltextzugriff (PDF)

Benefit-Risk Comparison in Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag or Romiplostim: Real World Evidence (RWE) from 26 Hospital Institutions

Blood, 2017-12, Vol.130, p.3409-3409

2017

Volltextzugriff (PDF)

Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review

International journal of general medicine, 2020-01, Vol.13, p.361-377

2020

Volltextzugriff (PDF)

Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices

Clinical genitourinary cancer, 2015-08, Vol.13 (4), p.309-318

2015

Volltextzugriff (PDF)

A systematic review to assess the burden of ischemic priapism in patients with sickle cell disease

Sexual medicine reviews, 2023-01, Vol.11 (1), p.52-60

2023

Volltextzugriff (PDF)

Comparison of real-world acute care interventions (ACI) in patients (pts) with advanced non-small cell lung cancer (adv NSCLC) treated with chemotherapy versus targeted therapies

Journal of clinical oncology, 2016-03, Vol.34 (7_suppl), p.37-37

2016

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(48)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sickle cell disease complications: Prevalence and resource utilization

Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study

The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease

Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett's Esophagus, and Barrett's Esophagus-Related Neoplasia in the United States

1145. Meningococcal B Immunization for Adolescents in the Presence of Added Gonorrhea Protection: A Public Health Impact Modelling Study in the United States

A Systematic Literature Review of the Burden of Ischemic Priapism in Patients with Sickle Cell Disease

For which diseases do broader value elements matter most? An evaluation across 20 ICER evidence reports

Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer

Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings

Real-world upper endoscopy utilization patterns among patients with gastroesophageal reflux disease, Barrett esophagus, and Barrett esophagus-related esophageal neoplasia in the United States

Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study

Cost-Consequence Model Comparing Eltrombopag and Romiplostim for Pediatric Patients with Previously-Treated Chronic Immune Thrombocytopenia

A Systematic Literature Review of Patient-Reported Outcome Instruments Used in Sickle Cell Disease

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices

Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective

Relationship between Vaso-Occlusive Crisis and Quality of Life: An Analysis of Patients with Sickle Cell Disease in the United States

How Does Sickle Cell Disease Severity Affect Patient Collection of Disability Insurance and Income: An Analysis of US Survey Data

Comparison of treatment characteristics between patients diagnosed with immune thrombocytopenia (ITP) and treated with thrombopoietin receptor agonists (TPO-RA)

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

Benefit-Risk Comparison in Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag or Romiplostim: Real World Evidence (RWE) from 26 Hospital Institutions

Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review

Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices

A systematic review to assess the burden of ischemic priapism in patients with sickle cell disease

Comparison of real-world acute care interventions (ACI) in patients (pts) with advanced non-small cell lung cancer (adv NSCLC) treated with chemotherapy versus targeted therapies

Aktive Filter

Suchergebnisse filtern